Mercury Systems, Inc. (MRCY) Earnings Call Transcript
May 5, 2026
Earnings Call Speaker Segments
Good afternoon, and thanks for being with us today. Joining me is Bill Ballhaus, our Chairman and Chief Executive Officer, along with Dave Farnsworth, our Executive Vice President and CFO. If you haven't yet gotten a copy of the earnings press release that went out earlier this afternoon, it's available on our website at mrcy.com. The slide presentation we'll be referring to can be found in the Investor Relations section of the website, under Events and Presentations. Now let's move to Slide 2 in the presentation. I want to remind everyone that forward-looking statements are part of today's presentation, including information about Mercury's financial outlook, future plans, objectives, business prospects and anticipated financial performance. Future risks and uncertainties apply to these forward-looking statements, and those could cause our actual results or performance to differ materially. All forward-looking statements should be considered alongside the cautionary statements on Slide 2 in the earnings press release, as well as the risk factors included in Mercury's SEC filings. I'd also like to note that beyond reporting financial results in accordance with generally accepted accounting principles, or GAAP, we will also discuss several non-GAAP financial measures during our call, specifically adjusted income, adjusted earnings per share, adjusted EBITDA and free cash flow. A reconciliation of these non-GAAP metrics appears as an appendix to today's slide presentation and in the earnings press release. I'll now hand the call over to Mercury's Chairman and CEO, Bill Ballhaus. Please turn to Slide 3.
Thanks, Tyler. Good afternoon, all, and I appreciate your joining us for the Q3 fiscal year '26 earnings call. Results for our third quarter exceeded our expectations, showing significant year-over-year increases in backlog, revenue, and adjusted EBITDA. The stronger-than-anticipated organic growth and margin improvement we saw this quarter stemmed from robust demand signals combined with disciplined execution. There are 3 topics I want to cover today: first, some initial comments on our business and results; second, an update regarding our 4 priorities — performance excellence, building a thriving growth engine, expanding margins, and driving free cash flow; and third, our outlook for performance through the rest of FY '26 and beyond the near term. Following that, I'll pass it over to Dave, and he'll walk everyone through the details of our financial performance. Before diving in, I'd like to express appreciation to our customers for working alongside us in partnership, and for trusting Mercury to back their most essential programs. My thanks also go out to the entire Mercury team for their hard work and dedication in providing mission-critical processing at the edge. If you'd please turn to Slide 4. During Q3, we saw strong organic growth along with margin expansion, bookings hit a record $348.3 million, and book-to-bill came in at 1.48, which pushed backlog to a record level nearing $1.6 billion. Revenue reached $235.8 million, an organic increase of 11.5% compared to the same period last year. We posted adjusted EBITDA of $36.1 million, which works out to a 15.3% adjusted EBITDA margin — that's a 46% jump and a 360 basis point gain compared with the same period last year. Free cash outflow came in at $1.8 million, which is a much better result than we had anticipated, and we closed out Q3 holding $332 million in cash. What these numbers show is that we've stayed focused on our 4 priority areas. Among the highlights: we're executing well right across our extensive lineup of production and development programs; backlog rose 18% versus a year ago, while 12-month backlog grew 10.3% quarter over quarter; our operating structure is leaner, which is letting us drive more positive operating leverage along with substantial margin expansion; and we keep making headway on the things that move free cash flow, with net working capital declining 4.1% from a year earlier. Now, if you'd go to Slide 5. We'll begin with the four areas we've prioritized, and for the first one — performance excellence — our emphasis is on solid execution of development efforts, speeding up handoffs to customers throughout our portfolio, and increasing output on many programs that are moving into larger-scale manufacturing. On quite a few programs we moved faster, producing roughly $25 million in revenue, $15 million in adjusted EBITDA, and $25 million in cash, nearly all of which had been scheduled for Q4. That pickup in speed came from the work we've done to get our suppliers lined up so we can turn backlog into revenue more quickly, and it helped push our top line, adjusted EBITDA margin, and free cash flow past what we had expected for Q3. It's also going to play into how we're thinking about Q4, which I'll get to in a moment. With bookings coming in strong and backlog at a record level, plus our improved ability to convert that backlog faster, we're now seeing organic growth that's beating the expectations we had going into FY '26. One thing worth calling out: domestic revenue made up roughly 88% of what we booked in Q3, and it grew 17% compared to the same period a year ago. In addition to that strong performance, during the quarter we moved forward on several actions aimed at boosting capacity, introducing automation, and combining smaller-scale locations as part of our continuous push for scalability and efficiency. In particular, we expanded capacity at our highly automated production site in Phoenix, Arizona, and began operating in the extra 50,000 square feet of factory space we added, which supports increased output for our common processing architecture programs and enables us to scale efficiently. During the quarter, we also closed our purchase of a key provider of manufacturing process technology that is essential to several of our major ramping programs. Those steps are part of a broader set of actions we've undertaken, together with earlier investments in various critical technology efforts that are strengthening our capacity to speed delivery of essential capabilities to our war fighters and allies. Please turn to Slide 6. Turning to priority 2, driving organic growth: we anticipate that near-term organic growth will come from higher volume on programs already in production as well as the continuing shift of several development programs into production. In addition, we foresee possible upside from potential tailwinds tied to customer-driven acceleration and greater quantities across a wide range of production programs in our portfolio. Finally, we're enthusiastic about new development programs and the production volume those wins could generate. During the third quarter, we achieved our best-ever performance, with $348.3 million in bookings. That resulted in a book-to-bill ratio of 1.48 and a record backlog that approached $1.6 billion. Over the past 12 months, our bookings hit an all-time high of $1.23 billion. Most of the Q3 bookings were follow-on production orders, which demonstrates strong customer demand across our core franchise programs. This bookings mix shows how our business is moving toward higher-rate production, and from our perspective, it doesn't truly capture the potential additional tailwinds we're seeing in the market. The largest bookings this quarter covered several missile, C4I and space programs. This quarter also delivered the fiscal year's best bookings for solutions based on our common processing architecture. Additionally, we secured a subsequent development contract for a key initiative that has the potential to extend to various platforms. Together with the increase in our backlog, we continue to observe opportunities for heightened demand across numerous programs in our portfolio, driven by growing global defense budgets and domestic focuses like Golden Dome. I remain hopeful that these potential market tailwinds might favorably impact our demand landscape should our customers direct funding toward specific program priorities over the next several quarters and beyond. Kindly refer to Slide 7. Moving on to priority 3, which is about margin expansion. To reach the adjusted EBITDA margins we're aiming for—somewhere in the low to mid-20% range—we're zeroing in on a few key levers: improving margins in our backlog as we turn lower-margin work into revenue and secure new orders that match the margin profile we want, keeping up our push to make operations simpler, more automated and more efficient, and fueling organic growth so that positive operating leverage increases. Our adjusted EBITDA margin for Q3 landed at 15.3%, above our expectations and up 360 basis points year over year. Our gross margin reached 29.3%, marking a 230 basis point increase year-over-year, and this aligns with what we expected — that average backlog margin will keep climbing as we work through older, lower-margin backlog and secure new bookings that we anticipate will match our target margin profile. Operating expenses have declined versus last year, both in absolute dollars and as a share of sales, which shows how we remain focused on constantly improving cost structure efficiencies so we can achieve significant positive operating leverage as organic growth speeds up. Kindly move to Slide 8. And now, on to priority 4, which is better free cash flow. We continue to make progress on the elements behind free cash flow, particularly in bringing down net working capital, which is now around $434.4 million — down $18.7 million from the same time last year. Net debt at the end of Q3 was $259.7 million. We believe the improvements we're making in how we execute programs, deliver more quickly to customers, plan for demand, and manage the supply chain will continue to yield a strong balance sheet, leaving us plenty of room to pursue and capture possible market tailwinds. Please turn to Slide 9. Looking ahead, I feel really good about our team's performance, where we're positioned strategically, the conditions in the market, and our confidence that we'll deliver results in line with the target profile we've set: revenue growth that outpaces the market, adjusted EBITDA margins in the low to mid-20% area, and free cash flow conversion of 50%. Our performance through this year so far, we believe, shows substantial progress toward that profile — an aggregate 1.3 book-to-bill, 9% growth on the top line, 15% adjusted EBITDA margins, a 400 basis point increase in EBITDA margin versus a year ago, and $39.5 million in free cash flow. Now that Q3 is behind us, we're raising our outlook for FY '26. We think our push to stage material sooner has enhanced revenue linearity and given us better forecast visibility, and that improvement is now captured in our revised expectations for FY '26. Consequently, our outlook factors in backlog conversion that in the past might have shown up in accelerations and results that exceeded forecast. Our Q4 bookings could end up being the strongest we've seen all year, given a pipeline of opportunities that's stronger than what we had in Q3, which we think might signal higher top line growth and additional margin expansion past FY '26. We now anticipate annual revenue growth for FY '26 to approach mid-single digits, an increase from low single digits; we expect full year adjusted EBITDA margin in the mid-teens, up from approaching mid-teens. And last, regarding free cash flow, we expect it to be positive in Q4; in short, with the positive momentum we've built year-to-date and coming off a very solid Q3, I anticipate that FY '26 performance will represent a significant step toward our target profile. On top of that, I'm growing more optimistic about the possibility that tailwinds tied to rising global defense budgets and domestic priorities such as Golden Dome will come to fruition and that we'll see upside bookings relative to our plan over time. Having said that, I'll hand things over to Dave so he can take us through the quarter's financial results, and I'm eager to get to your questions. Dave?
Thanks, Bill. The results we posted for the third quarter show us carrying on with strong momentum as we pursue our objective of organic growth paired with margin expansion. There is still more to be done before we hit the profile we're targeting, yet the strides we've taken give us confidence, and we look for that momentum to carry on ahead. On that note, if you'd go to Slide 10, you'll find the details of our third quarter results. Bookings came in at roughly $348 million for the quarter, with a book-to-bill of 1.48. Backlog reached a record of close to $1.6 billion, an increase of $240 million, or 17.9%, versus the prior year. Third quarter revenues totaled just under $236 million, which is an increase of about $24 million, or 11.5% on an organic basis, from a year ago. Once again in the third quarter, we managed to pull forward work on several customers' high-priority programs, representing about $25 million in revenue, most of which had been slated for the fourth quarter of FY '26. Gross margin came in at 29.3% for the third quarter, roughly 230 basis points higher than the same period a year earlier. The improvement in third quarter gross margin came mainly from net EAC change impacts that were nearly $2 million lower and net manufacturing adjustments that were about $4 million lower; those gains were partly offset by inventory reserves that were roughly $3 million higher. As Bill mentioned earlier, we anticipate gross margin performance will strengthen over time as the average margin in backlog rises and as we keep working to simplify, automate and optimize our operations. We expect the average backlog margin to keep climbing as we work through lower margin backlog and add new bookings that we believe will align with our targeted margin profile. Operating expenses fell by about $11 million, or 14.3%, from a year ago. The drop in operating expenses came mainly from reduced restructuring and other charges, selling, general and administrative expenses and research and development costs, which were down by approximately $5 million, $4 million and $1 million, respectively. Those reductions mirror the efficiency gains and headcount cuts we talked about before, which were meant to match our team composition to our higher production mix and thereby drive better operating leverage. GAAP net loss and loss per share for the third quarter were roughly $3 million and $0.04, respectively, versus GAAP net loss and loss per share of approximately $19 million and $0.33, respectively, in the same quarter a year ago. Adjusted EBITDA for the third quarter came to about $36 million, an increase of $11 million, or 46.2%, from the same quarter last year. That gain was partly the result of better execution and improved operating leverage. Adjusted earnings per share was $0.27, compared with $0.06 a year earlier. The rise from the prior year stemmed mainly from stronger execution and greater operating leverage in the current period relative to last year. Free cash flow in the third quarter was an outflow of about $2 million, versus an inflow of $24 million a year earlier. Like we mentioned during the previous quarter, a free cash outflow for Q3 was anticipated. Even so, we managed to offset a substantial share of that outflow by collecting more effectively on billed receivables. On Slide 11, you can see Mercury's balance sheet covering the past 5 quarters; cash and cash equivalents stood at $332 million when the third quarter closed, up roughly $62 million, or 23%, versus the equivalent period a year earlier. The main driver behind this gain was free cash flow of about $73 million over the last 12 months, partly offset by $15 million in shares bought back and retired under our repurchase program earlier in this fiscal year. Billed receivables fell sequentially by around $10 million, while unbilled receivables declined about $4 million; our expectation remains that factory capacity in Q4 will go toward programs carrying unbilled receivable balances, which should help generate free cash flow while barely affecting revenue. Inventory rose about $12 million from the prior quarter. That climb came mainly from work in process as we finish bringing product to its final state to support a larger share of point-in-time revenue across many of the company's production programs. Prepaid expenses and other current assets dropped roughly $10 million sequentially, largely because of insurance proceeds and routine operating expenses. Accounts payable declined by about $2 million quarter over quarter, mostly from the timing of supplier payments. Accrued expenses fell roughly $3 million sequentially, chiefly from payments tied to the legal settlement and restructuring actions announced earlier in this fiscal year. Accrued compensation grew about $2 million sequentially, mainly from our incentive compensation plans. The amount owed to our factoring facility shrank by around $18 million sequentially, mostly because of the timing of customer payments owed back to our counterparty. Deferred revenues declined about $11 million sequentially, primarily from execution across a number of programs during the period. Working capital dropped about $19 million year-over-year, or 4.1%. Ongoing year-over-year working capital improvement, reflected in our strong balance sheet position, has allowed us to make a $150 million payment against our revolver during Q4; this further shows the progress achieved in reversing the multiyear pattern of working capital growth, producing a reduction of roughly $225 million, or 34%, from peak net working capital in Q1 fiscal '24. Our balance sheet gives us ample flexibility to pursue and capture possible market tailwinds. Moving to cash flow on Slide 12. Free cash flow in the third quarter was a slight outflow of about $2 million, compared with an inflow of $24 million a year earlier. We still expect free cash flow to be positive for the year, with positive cash flow anticipated in Q4, as Bill mentioned earlier. Our ongoing gains in how we run programs, get hardware out the door, bring in materials right when needed, and set payment terms at the right moments should keep driving working capital down. To wrap up, we feel good about how the third quarter went and about the greater predictability we're seeing in the business. We think that if we keep delivering on our 4 priority areas, that won't just push revenue growth and profitability — it will also bring additional margin expansion and cash conversion, which shows the potential our business has for creating value over the long term. So with that, I'll hand the call back to Bill now.
Thanks, Dave. With that, operator, please proceed with the Q&A.
Bill and Dave, truly impressive results. Yes. Bill, perhaps to begin with the margins implied for Q4 on a seasonal basis—normally you get a solid step-up as you enter the fourth quarter. The updated full-year outlook suggests a more modest margin improvement heading into Q4. Maybe you could walk through a few of the puts and takes for the fourth quarter; and then, I suppose, more significantly, without getting too far ahead, how much of the progress toward the longer-term target in the low 20s might we see in fiscal '27?
Yes. Ken, this is Dave. If that's fine, I'll kick things off and then Bill can chime in. Regarding the sequential margin growth, that's something we've witnessed previously, and it came alongside a truly substantial shift in how linear our business is. As you remember, during the fourth quarter, revenue has usually been higher and the mix has looked somewhat different; and one thing we've managed to accomplish this year is begin to smooth out that linearity somewhat; so a better Q3, with improved margins coming with Q3 too. So whereas previously, we'd see a step-up of possibly a couple of hundred basis points, it started from a far lower base typically; and so we don't anticipate such a big jump in the fourth quarter, more of a steady kind of progression, but we're optimistic about the full year. And like Bill mentioned, mid-teens for the margin across the year; and we genuinely believe we're moving in exactly the right direction and consistent with what we expect as we work toward our target margins.
Yeah. What I'd probably add here is that the point Dave made really captures how the business has moved along quite steadily — from a couple of years back, when there was a heavy concentration, a large proportion of development programs all bunched together, through to wrapping those programs up, shifting into low rate production, and afterward ramping production higher. As things have developed, what we anticipated was a blend of rising top line growth plus even more acceleration on the bottom line. When you strip out some of what got pulled forward from this year into last year, into Q4, the result has been a fairly steady climb from mid-single-digit top line growth to high single-digit top line growth at present, along with solid margin expansion on the bottom line, and then a few recent signs that this keeps going as we move ahead. A couple of items I'd highlight: our domestic business grew in Q4, rising 17% year-over-year. Also, during the quarter, our next 12 months of backlog took a really nice step up, climbing 10% from Q2 to Q3. So above all else, Ken, I think what Dave said about linearity — we're simply witnessing a pleasant, steady progression in the business.
That sounds excellent, and I appreciate it, Bill. If we could hear from either Dave or Bill — when we consider how robust the bookings were this quarter, you mentioned, or rather you pointed to, missiles, C4I, and certain space programs. Within those wider categories, are there specific programs you feel at ease naming, or that you would particularly flag as major drivers of bookings?
This is something we've addressed before — a genuine strength of ours lies in how diversified our portfolio is, with no meaningful concentration. No individual program accounts for over 10%. What the solid bookings show is simply robust demand throughout our portfolio in fields such as space, C4I, and missile defense, and we regard that as a truly valuable characteristic of our business. There's no lone program, no actual lumpiness when it comes to bookings — just, in my view, a clear signal of demand spanning our extensive portfolio.
Correct. And it genuinely is, as we've discussed, when we take a look, there isn't a single segment where we'd say, oh, this one is really moving — this one is the kind of segment you wouldn't put much effort into since it's either shrinking or staying level. I mean, every segment, from a booking perspective, is experiencing healthy activity, and that matches up with what's happening in the market. And all of these — to a significant extent, these reflect the production work we've mentioned, and this amounts to ramping up additional production on those very same programs we've been engaged with.
Yeah, it truly shows, once more, that shift away from a strong focus on development toward subsequent production orders. So that's a good step forward during the quarter.
That was a really strong quarter. Ken already covered margins, so I'll focus on revenue, which came in very strong this quarter. Your overall tone also seemed more upbeat regarding the sales outlook, and you've lifted the guidance into the mid-single-digit range. Yet even with that guidance, it appears Q4 revenue would be down compared with a year earlier. So I'm wondering whether the guide still holds some conservatism, or whether there's simply a big share of unbilled receivable-type work landing in Q4 versus Q3, or perhaps something different?
Yes. One way to look at it, at least, is that if you set aside the $30 million we pulled forward from Q1 of FY '26 into Q4 of last year, the comparison of growth versus a year ago and the top line expansion appears fairly consistent with how Q1, Q2 and Q3 came in. So once more, it's more a reflection of our business steadily progressing toward roughly mid-single digits last year and then high single digits this year, with what I see as some genuinely positive signals, again, tied to book-to-bill and the ongoing expansion of our backlog, which we anticipate will keep growing. And then especially the share of that backlog we expect to convert within the next 12 months.
All right, and moving on to unbilled receivables — those fell just slightly during this quarter. How should we interpret that? Is it a sign that certain of these cycles will simply stretch out much further? Honestly, I'm somewhat puzzled about why the drop in receivables wasn't larger.
Yeah, Dave speaking once more. Part of what you're picking up there, I believe, relates to our inventories and reflects the upward cycle we're experiencing as this production arrives. So timing always plays some role in this. And a slight decrease is what you're observing. Earlier there was a far bigger decrease, yet items got added while we were ramping up new activities; so it's really nothing beyond how the timing works out. I wouldn't infer anything further from it; burning down certain older unbilled balances remains our focus. However, as revenue ramps up, fresh unbilled balances will appear — definitely with improved terms compared to what existed previously, yet some will emerge purely from a timing perspective; so nothing differs from what we've consistently stated here. Our capacity continues to be directed toward processing the older balances and removing them from our books. Thus we possess the capacity for all the new work we foresee.
Even so, there's certainly a lot more going on beneath the surface than the quarter-over-quarter figure alone would suggest. And Pete, here's another point worth mentioning: we're seeing growth of nearly 12% compared with a year earlier, yet net working capital has declined versus the same period a year ago in spite of that expansion — which I believe speaks to the strides we keep making and to how much more efficiently our net working capital is now operating.
I'd like to know whether the IBAS defense industrial base investments fall within what you're examining in the fiscal year '27 budget. Also, might there be chances to secure additional funding through that program so your capacity could be expanded?
Austin, I appreciate that question very much. Interactions with IBAS have taken place on our end, they keep happening, and programs funded by IBAS are something we have, which remains a space where we seek out chances to pursue what they want to put money into, and in our view that can grow our capacity along with our efficiency and our innovation. So yes, that is certainly something sitting right in front of us.
Great. For my next question, where do you expect to find more contract opportunities — inside Golden Dome, or inside the Defense autonomous working group in the fiscal year '27 budget request?
Well, I'd say we certainly see chances in every area; and that applies not just to the portfolio of programs we already have, but also relates to administrative priorities such as Golden Dome, missile defense, armament — pretty much everywhere at the moment, we're finding opportunities; and we believe our capabilities line up quite well with what the administration prioritizes overall. And as we've mentioned previously, one thing we consider distinctive about where we sit is that we're exposed to a wide range of tailwinds throughout the market, and capturing those is our focus right now.
Eegan McDermott here, filling in for Sheila.
That didn't sound like Sheila to me.
No. Perhaps I could just pick up where those earlier missile-related questions left off. I'm wondering two things: first, could you give even a rough estimate of how much of Mercury's sales comes from missile exposure, as a percentage? And second, given that a few sizable LTAMDS contracts have appeared recently — something like that $8 billion FMS to Kuwait — how should we think about what an order of that size would mean for your business?
Yes. I appreciate you asking. What I'd say is we don't break out the scale of our missile portfolio, though we certainly have a number of programs that carry missile exposure. When it comes to LTAMDS, our usual practice is not to discuss any individual program or provide much detail. What I can say is that it's publicly known that there are discussions about greater demand and higher quantities for LTAMDS, and that hasn't yet been reflected in any of our bookings, but it would definitely be a favorable development if quantities rose and deliveries sped up; and as we look ahead, it's among the possible tailwinds we're watching.
And perhaps a quick additional question related to that. Would it be reasonable to assume that profitability for an order such as the one from Kuwait, or other FMS deals, might be different from U.S. orders, or possibly even greater?
Indeed. In our case, this is usually something handled alongside the prime contractor; therefore we'd collaborate with them to determine what pricing is appropriate and in what manner. Generally, at the prime level, foreign direct contracts carry higher margin rates compared to FMS contracts; thus, that's a matter you would need to discuss in a broad sense with the prime.
This is <<inaudible>> filling in for Jonathan. I'm happy to see such solid results, and it appears demand is robust and fairly widespread across the board. That said, are there particular areas, or more generally, where do you anticipate the greatest chance for reordering and restocking activity in the near term, considering the continuing geopolitical conflicts.
Yes. No, I appreciate the question. Let me sort of unpack our growth vectors. Above all, the main force behind our near-term organic growth is the shift of our business away from a really heavy focus on development programs — and it's dozens of programs. It's not 1 or 2, it's dozens of programs — into low rate production and afterward the higher rate production phase. So we're watching that begin to show up in '25 to '26 and anticipate our organic growth will keep accelerating as those programs ramp up. And that truly has nothing to do with tailwinds that we see in the market. Past the existing portfolio, we keep winning new development programs that are genuinely exciting, where we're combining technology and innovation from throughout our portfolio, accomplishing things that nobody else can do and winning new development programs that over time will add to that production content. And then past those 2 items, we do see a number of potential tailwinds connected to a number of different factors, the size of the domestic budgets, the size of the global budgets and then other tailwinds such as Golden Dome, rearmaments, acceleration of munitions. And we're beginning to see those tailwinds show up in the form of multiyear strategic agreements at increased quantities, increased deliveries with the primes; and at present, none of those tailwinds are reflected in any of our bookings or our outlook, and we consider them all additive to the target profile that we've talked about and are converging on. We have said for a couple of quarters now that we think that some of those tailwinds could begin to show up likely by the end of calendar '26, but potentially as early as our fourth quarter, which obviously is our current quarter. And we're obviously monitoring those items as they advance in our pipeline with a lot of excitement. So past that, there's a broad set of demand, a lot of tailwinds right now that we have exposure to, and we're eager to see how that all plays out over the next quarter and beyond.
Absolutely. The only point I'd tack on comes from what's happening in the business right now — the things we're carrying out today. If you check the Q, you'll notice which areas show meaningful revenue growth. Bill was describing that on a go-forward basis, but space, for us, is clearly up a lot. Radar is also higher, which is what you'd expect, along with other sensors and effectors — and if you think about effectors, those are up substantially in our revenue so far this year. Those are items the customer wants delivered as quickly as possible. So you're seeing that, but from an opportunity and pipeline perspective, as Bill mentioned, there's just a major step up — really across the board. You'll see it throughout our whole portfolio of 300 programs.
Absolutely, and one of the strongest signs of that, once again, is the way our domestic business has climbed 17% compared with a year earlier. A few years back, that was the area where many of our development programs sat within the portfolio, and now you can clearly observe what happens when those development programs finish, shift into slower-rate production, and then begin to scale up. So there's plenty happening across the portfolio and the business that has us enthusiastic.
Good numbers. Bill, over the past several quarters you've frequently brought up how you can now stage material sooner and get your supply base aligned more effectively, which is driving stronger top-line results. Could you give us some additional detail on that staging approach, or perhaps a bit more color?
Sure. In my view, this ranks among the major gains in the business. We still aren't finished — there's more work ahead on this front — yet this quarter shows what our efforts have produced, both in linearity and in how we see the year unfolding. Keep in mind, roughly 3 years back, we pushed the pendulum strongly toward a just-in-time delivery model for material. That shift happened mainly because net working capital had built up and we needed to deal with it. So we made that hard swing. The benefit is that we've cut net working capital by roughly $250 million across the past 2 years, yet it genuinely created certain limits on how quickly we could convert backlog. It wasn't that material or items in our supply chain were difficult to obtain. Rather, we had simply staged delivery to the right owing to the net working capital buildup in the business. As time passed, we've accelerated material delivery, producing the accelerations we mentioned in prior quarters. That, however, created a bathtub in later quarters, making it difficult to predict what a given quarter would look like, since many unknowns surrounded building the bathtub and attempting to speed up additional material. Thus, across the past several quarters, we've concentrated on pulling our supply chain to the left, moving material due dates earlier than our need date, giving us greater flexibility and more degrees of freedom in converting backlog. What that has delivered is a higher organic growth rate and the ability to convert backlog more quickly than we anticipated when the year began. So it's a terrific change for the business. We're quite enthusiastic about it. There's still more work ahead; however, for upcoming quarters, it provides far better visibility into our deliveries, and we can factor that into our forecast; that's a pivot and a transition we completed this quarter. So I hope that helps clarify the dynamics.
Yeah, that's pretty helpful. And if I could, I'd like to ask about — you mentioned the CPA, or common processing architecture, had its strongest bookings quarter. So it really looks like momentum is building in that space. What more detail could you give me about the CPA and what you're seeing from customers?
Well, I think we have quite a few different levers we can pull to generate growth there. In other words, we've said all along that once we can increase production, the follow-on bookings would come; and we're definitely seeing that happen, and this quarter proves it. Demand is strong right now for what's already in our lineup. And again, in this particular area we've got a differentiated position in the market, plus there are specific security requirements that nobody but us can satisfy. That gives us a pretty solid moat around the business. And now that we've made headway on the development programs, we've got the opportunity to zero in on the next wave of innovations we plan to launch. You're seeing that show up as better performance across the form factors we already have. Which means getting the newest processing and memory into our customers' hands, all tied together by our shared processing architecture. Beyond that, what might be even more thrilling is our ability to move toward more compact designs and protected chiplet architectures, which in my view unlocks a substantial total addressable market for that kind of solution. So across the past two years or so, we've made considerable headway on our development initiatives and our technology. As a consequence, follow-on production orders are now coming in, and we believe there's considerable opportunity ahead to expand into various form factors and thereby broaden the market. Down the road, as we push mission-critical processing out to the edge, boost performance, and work toward more compact form factors, we expect to be in a position to deliver the compute infrastructure required for AI spread throughout the battle space. That is the opportunity we anticipate being able to seize with this capability going forward.
Alright, that brings us to the end of today's call. We truly value everyone taking part and showing interest, and we can't wait to reconnect with you in the next quarter. Thanks so much.
This concludes today's call. Thank you for attending. You may now disconnect.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Mercury Systems, Inc. transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Mercury Systems, Inc. earnings transcripts and 132,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.